跳至主要内容
临床试验/NL-OMON37058
NL-OMON37058已完成4 期

PercutAneous Ventricular RestorAtion In Chronic Heart failure due to Ischemic HearTDiseasE-III - PARACHUTE III

CardioKinetix Inc.0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • *Akinesis or dyskinesis due to myocardial infarction limited to anteroapical region
  • * Subject is not hospitalized at time of enrollment.
  • * NYHA Class at time of enrollment, either:
  • NYHA Class III or Ambulatory IV * if predominant during the 3-month period prior to enrollment
  • NYHA Class II * if diagnosed with NYHA Class III or IV during 3-month period prior to enrollment
  • * LVEF >15% and* 40% as measured by echocardiography.
  • * Post LV MI structural heart dysfunction represented by LV wall motion abnormality (WMA) by
  • echocardiography.
  • * Receiving appropriate medical treatment for heart failure according to the ACC/AHA 2009 Guideline
  • - Update for the Diagnosis and Management of Chronic Heart Failure in the Adult during the three
  • months prior to enrollment

排除标准

  • * Untreated clinically significant coronary artery disease requiring intervention.
  • * Acute MI (see MI definition) within 60 days of enrollment or patients with suspected evolving MI at time of enrollment
  • * Cardiogenic shock within 72 hours of enrollment
  • * Revascularization procedure (PCI or CABG) within 60 days of enrollment
  • * Patient has received a pacemaker, ICD, or CRT device within 60 days of enrollment
  • * History of aborted sudden cardiac death, if patient has not received an ICD and has potentially lethal ventricular arrhythmia, VT or VF
  • * Aortic valve replacement or repair
  • * Blood dyscrasia, history of bleeding diathesis or coagulopathy, or hypercoagulable states.
  • * Active peptic ulcer or GI bleeding within the past 3 months
  • * Patient has suffered a cerebrovascular accident (CVA) or transient ischemic attack (TIA) within
  • the past 6 months
  • * History of Kawasaki*s disease
  • * Ongoing sepsis, including active endocarditis.
  • * Anatomical characteristics not suitable for treatment with the Parachute Implant device as
  • screened by the echocardiography core lab. (characteristics include inappropriate size and shape
  • of the left ventricle, presence of LV apical thrombus, pseudo chordae or trabeculations)

研究者

相似试验